You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Correlating TCR diversity to immune reconstitution after cord blood transplant
SBC: ADAPTIVE BIOTECHNOLOGIES CORPORATION Topic: NHLBIDESCRIPTION provided by applicant Many patients requiring stem cell transplantation for hematological malignancies are unable to find a suitable HLA matched sibling or unrelated donor Transplants using stem cells from umbilical cord blood provide an alternative for these patients allowing transplantation to proceed with less stringent HLA matching requirements Unfortunately in addition to t ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Unicondylar Resurfacing in an Ovine Osteoarthritis Disease Model
SBC: Cytex Therapeutics, Inc. Topic: NIAMSAbstractThe treatment of large cartilage lesions is a difficult clinical problem for which there are few good solutionsLeft untreatedthese lesions tend to degenerate to chronic pain and osteoarthritisOAultimately requiring a total joint replacementFor patients suffering from knee OAandin particularunicompartmental OAunicondylar knee arthroplastyUKAis an available first line treatment option that p ...
STTR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
A Socket-Suspension Monitoring System for Lower Limb Amputees with Roll-on Liners
SBC: ASSIST EQUIPMENT DEVELOPMENT INC Topic: NAThe focus of this project is to develop a low-cost, wearable, easy to use, continuous socket/suspension monitoring system (SSMS) that tracks the relative displacement between the amputees’ residual limb and their socket or pistoning through the use of magnetic sensors. To do this, the project (1) designs and constructs the SSMS and demonstrates its capability through a bench top experiment; (2) ...
SBIR Phase I 2017 Department of Health and Human ServicesAdministration for Community Living -
PLATFORM FOR NEUROCOGNITIVE EVALUATION AND MONITORING
SBC: ENFORMIA INC. Topic: NCICurrent standardized neuropsychological tests are based on decades old paper and pencil methods They lack reliability sensitivity specificity repeatability and require trained neuropsychologists to administer them Their administration in clinical and research settings result in high cost complexity and inconsistent results There is a need and a commercial opportunity for an extensible co ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
An RNA targeted platform for anti flavivirus drug discovery
SBC: Ribometrix LLC Topic: NIAIDSUMMARY Emerging and re emerging mosquito borne flaviviruses cause widespread mortality morbidity and economic burden Options for prevention and treatment of mosquito borne flaviviruses are limited Flavivirus vaccines face unique development challenges no antiviral therapies are available and the mosquito vectors have proven difficult to eradicate Despite vaccines against Yellow Fever and J ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Long non coding RNA signatures to distinguish fibromyalgia syndrome from rheumatic diseases
SBC: IQuity Labs, Inc. Topic: NIAIDNo other group of diseases encompasses a greater pathophysiology than do the rheumatic diseases Spanning multiple organ systems clinical decisions often rely on coordinated efforts from primary care providers and rheumatologists to rule in or rule out differential diagnoses when treating inflammatory conditions such as rheumatoid arthritis RA and systemic lupus erythematosus SLE RA is a sym ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Development of an Innovative Effective RNA based Vaccine for Chikungunya Virus
SBC: PAI LIFE SCIENCES INC Topic: NIAIDPROJECT SUMMARY ABSTRACT Chikungunya virus CHIKV is an emerging disease of global public health importance Originally identified in sporadic CHIKV outbreaks occurred in Africa and Asia for several decades Beginning with an outbreak on the island of La Reunion in the virus has continued to spread to new regions around the globe CHIKV is now endemic in the Caribbean is present in t ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Aerosol Sampling and Microfluidic Analysis of Reactive Oxygen Species
SBC: ILLIONIX, LLC Topic: 113DESCRIPTIONprovided by applicantCardiovascular diseases and Asthma affects betweenandmillion people in the United States includingmillion childrenduring the pastyearsits incidence worldwide has doubledAsthma is responsible formillion person days of restricted activity anddeaths per yearamounting to $billion in direct heath related coststhere is uncertainty about the specific factors that are contr ...
STTR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Development of user-friendly fluorescence based assays for marine toxins
SBC: SEATOX RESEARCH INC Topic: 113ABSTRACTHarmful algal bloomsHABsare becoming frequent occurrences off the coasts of the United Stateswith specific instances in the coastal waters of the west coastthe Gulf of Mexicoand the Pacific OceanHistoricallyHABs have been associated with fish kills and marine mammal mortalitieshowevertheir effects on human health and economic loss due to HAB contamination of seafood are becoming more preva ...
STTR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Peptide based tool for the rapid isolation of quiescent monocytes from peripheral blood
SBC: AFFINERGY, LLC Topic: 102SUMMARY ABSTRACT Dendritic cell DC therapy represents a new and promising immunotherapeutic approach for treatment of advanced stage cancers with DC vaccines already approved for use in advanced prostate cancer and more than DC based vaccines in the clinical development pipeline for other cancers In particular the US market for cancer vaccines including DC based vaccines is set to expan ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health